Carlo Acierno

Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease

Ferdinando Carlo Sasso, Pia Clara Pafundi, Vittorio Simeon et al. · Cardiovascular Diabetology · 2021 · 132 citations · Full text

Medicine, Internal Medicine, Nephrology +17

Non-Alcoholic Fatty Liver Disease: From Pathogenesis to Clinical Impact

Alfredo Caturano, Carlo Acierno, Riccardo Nevola et al. · Processes · 2021 · 105 citations · Full text

Veterinary Medicine, Biochemistry, Inflammation +16

The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial

Ferdinando Carlo Sasso, Vittorio Simeon, Raffaele Galiero et al. · Cardiovascular Diabetology · 2022 · 73 citations · Full text

Medicine, Cardiology, Internal Medicine +17

High HDL cholesterol: A risk factor for diabetic retinopathy? Findings from NO BLIND study

Ferdinando Carlo Sasso, Pia Clara Pafundi, Aldo Gelso et al. · Diabetes Research and Clinical Practice · 2019 · 72 citations

Medicine, Ophthalmology, Diabetology +13

Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin

Carlo Acierno, Alfredo Caturano, Pia Clara Pafundi et al. · Exploration of Medicine · 2020 · 70 citations · Full text

Medicine, Biochemistry, Endocrinology +17